Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Dermatology

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 100 articles: HTML format

Single Articles

March 2026
1. CUI W, Xiao H, Wen X, Li C, et al
   Identifying a cancer therapeutic target: Cell-SELEX identifies a membrane protein for aptamer-mediated growth suppression.
   Proc Natl Acad Sci U S A. 2026;123:e2514681123.
   PubMed     Abstract available
   
   
   
2. FASSL A, Palacios Espinoza M, Butter D, Kolodziejczyk A, et al
   Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6.
   Proc Natl Acad Sci U S A. 2026;123:e2522872123.
   PubMed     Abstract available
   
   
   
3. DING XH, Chen F, Yang F, Di GH, et al
   Phase separation of DDHD2 remodels lipid metabolism to dictate treatment sensitivity in luminal breast cancer.
   Proc Natl Acad Sci U S A. 2026;123:e2503019123.
   PubMed     Abstract available
   
   
   
4. TSOKKOU P, Holcmann M, Rindler K, Mieczkowski K, et al
   Psoriasis-like disease prevents squamous skin tumor development by neutrophil-driven inflammation.
   Proc Natl Acad Sci U S A. 2026;123:e2536378123.
   PubMed     Abstract available
   
   
   
5. CHEN HC, You SL, Lin CH, Sun CW, et al
   Elevated phthalate exposure and metabolic susceptibility increased breast cancer risk: A 20-y follow-up study in Taiwan.
   Proc Natl Acad Sci U S A. 2026;123:e2507008123.
   PubMed     Abstract available
   
   
   
6. COTTRELL O, Rowntree A, Chopra K, Mackellar E, et al
   HES1 oscillations are required for cell cycle reentry in oestrogen receptor-positive breast cancer cells.
   Proc Natl Acad Sci U S A. 2026;123:e2520724123.
   PubMed     Abstract available
   
   
   
7. GAO Y, Wang J, Qin Z, Xu N, et al
   NMI promotes the secretion of IL-17 and exacerbates psoriasis.
   Proc Natl Acad Sci U S A. 2026;123:e2511535123.
   PubMed     Abstract available
   
   
   
8. SENTHILKUMAR I, Vangheel J, Kumar V, McNamara L, et al
   Stress-dependent growth in breast cancer arises from a mechano-osmotic coupling and cell-sizing checkpoint.
   Proc Natl Acad Sci U S A. 2026;123:e2523159123.
   PubMed     Abstract available
   
   
   February 2026
9. YAN P, Bui T, Rojas Jimenez E, Kuang Y, et al
   Aging-associated differences in mammary tumor-initiating populations and immune evasion pathways in breast cancer.
   Proc Natl Acad Sci U S A. 2026;123:e2523254123.
   PubMed     Abstract available
   
   
   
10. LOU KL, Bai JW, Liu HT, Lin LL, et al
    TROP2-targeted NIR-II fluorescence imaging for visualizing surgical margins and metastatic sentinel lymph nodes in breast cancers.
    Proc Natl Acad Sci U S A. 2026;123:e2519420123.
    PubMed     Abstract available
    
    
    
11. BAIRD MA, Jewett CE, Malide DA, Kratz L, et al
    Lamin B receptor upregulation in metastatic melanoma causes nuclear envelope fragility in confined migration during cancer invasion.
    Proc Natl Acad Sci U S A. 2026;123:e2513031123.
    PubMed     Abstract available
    
    
    
12. ROJAS-JIMENEZ E, Bui TM, Yan P, Li Z, et al
    Evaluation of targeted and immune combination therapies in a rat model of hormone receptor-positive breast cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2501052123.
    PubMed     Abstract available
    
    
    
13. SERRA M, Rediti M, Collet L, Lifrange F, et al
    Spatial transcriptomics reveals tumor microenvironment-driven subtypes of invasive lobular carcinoma.
    Proc Natl Acad Sci U S A. 2026;123:e2517567123.
    PubMed     Abstract available
    
    
    
14. NADAV-ELIYAHU S, Bohrer C, Boocholez A, Kinor N, et al
    Nuclear speckles are regulatory hubs for viral and host mRNA expression during HSV-1 infection.
    Proc Natl Acad Sci U S A. 2026;123:e2511555123.
    PubMed     Abstract available
    
    
    January 2026
15. MORRISSEY RL, McDaniel JM, Chau GP, Su X, et al
    Elucidating cooperative genetic events in DCIS progression in mutant p53-driven breast cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2526544123.
    PubMed     Abstract available
    
    
    December 2025
16. WANG J, Guo L, Tao Y, Xiao Y, et al
    Dysregulated NAMPT signaling underlines the immune-suppressive microenvironment in venous leg ulcers.
    Proc Natl Acad Sci U S A. 2025;122:e2512142122.
    PubMed     Abstract available
    
    
    
17. COLLURA JL, Lei KC, Chandra M, Kervarrec T, et al
    Pharmacologic reversion of Merkel cell carcinoma via CBP/p300 inhibition.
    Proc Natl Acad Sci U S A. 2025;122:e2516667122.
    PubMed     Abstract available
    
    
    
18. DELALEU J, Burstein V, Ansaldo E, Becaccece I, et al
    Maladaptive immunity to the microbiota promotes neuronal hyperinnervation and itch via IL-17A.
    Proc Natl Acad Sci U S A. 2025;122:e2525146122.
    PubMed     Abstract available
    
    
    
19. PANWAR HS, Vos TJ, Xie X, Jang HJ, et al
    Interprotomer communication and functional asymmetry in H/ACA snoRNPs.
    Proc Natl Acad Sci U S A. 2025;122:e2514683122.
    PubMed     Abstract available
    
    
    
20. FINCK AV, Wang Z, Gonzales D, Wellhausen N, et al
    Dual-targeted ping-pong CAR T cells: Leveraging peripheral expansion to improve solid tumor immunotherapy.
    Proc Natl Acad Sci U S A. 2025;122:e2518996122.
    PubMed     Abstract available
    
    
    
21. WANG X, Sun J, Lan B, Wang C, et al
    Asparagine endopeptidase prompts breast cancer-related pericardial calcification by regulating IGF2 and integrin alphavbeta5.
    Proc Natl Acad Sci U S A. 2025;122:e2512936122.
    PubMed     Abstract available
    
    
    
22. REINA J, Vallmajo-Martin Q, Ning J, Michi AN, et al
    LHPP expression in triple-negative breast cancer promotes tumor growth and metastasis by modulating the tumor microenvironment.
    Proc Natl Acad Sci U S A. 2025;122:e2505653122.
    PubMed     Abstract available
    
    
    November 2025
23. KLOSOWSKI ML, Cronise KE, Palmer EP, McAuliffe K, et al
    Breast cancer cell coculture induces normal lung fibroblast transition to CAFs, promoting tumor cell dormancy and therapy resistance.
    Proc Natl Acad Sci U S A. 2025;122:e2423894122.
    PubMed     Abstract available
    
    
    
24. WANG Z, Zeng Y, Tan Z, Chen Y, et al
    A unified framework for identification of cell-type-specific spatially variable genes in spatial transcriptomic studies.
    Proc Natl Acad Sci U S A. 2025;122:e2503952122.
    PubMed     Abstract available
    
    
    
25. LI Y, Qiu X, Sandusky Z, Tagliaferri K, et al
    METTL3-dependent m6A RNA methylation suppresses aberrant mammary epithelial differentiation and neoplastic transformation.
    Proc Natl Acad Sci U S A. 2025;122:e2514643122.
    PubMed     Abstract available
    
    
    
26. WU CCN, De Luna N, Hairston E, Jeffs ED, et al
    FZD7 expression marks mammary tumor-initiating cells.
    Proc Natl Acad Sci U S A. 2025;122:e2522465122.
    PubMed     Abstract available
    
    
    
27. NAWILAIJAROEN Y, Rocliffe HR, Austin-Williams S, Krilis G, et al
    MC1R determines healing outcomes in acute and chronic cutaneous wounds.
    Proc Natl Acad Sci U S A. 2025;122:e2503308122.
    PubMed     Abstract available
    
    
    
28. AYLON Y, Furth N, Pirona AC, Lavie A, et al
    p53 regulates the expression of histone modifiers to restrict stemness and maintain differentiated luminal identity in breast cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2522646122.
    PubMed     Abstract available
    
    
    October 2025
29. PIERCE SB, Kortbawi H, Gulsuner S, Mandell JB, et al
    Genetic regulation of the estrogen receptor and inherited predisposition to breast cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2517736122.
    PubMed     Abstract available
    
    
    
30. BERGMAN RE, Keeton CI, Sinha IR, Ling JP, et al
    Distinct and convergent effects of SF3B1 mutations in human breast cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2505374122.
    PubMed     Abstract available
    
    
    September 2025
31. SAGLIMBENI J, Esteva E, Canales J, Perez OA, et al
    Peritumoral macrophages recruit eosinophils to promote antitumor immune responses in breast cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2504645122.
    PubMed     Abstract available
    
    
    
32. ZHANG J, Zhang J, Han L, Wu S, et al
    Inflammation awakens dormant cancer cells by modulating the epithelial-mesenchymal phenotypic state.
    Proc Natl Acad Sci U S A. 2025;122:e2515009122.
    PubMed     Abstract available
    
    
    
33. DANG CAO TL, Kawanishi K, Hashimoto S, Hengphasatporn K, et al
    Tumor-expressed GPNMB orchestrates Siglec-9(+) TAM polarization and EMT to promote metastasis in triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2503081122.
    PubMed     Abstract available
    
    
    
34. PERLA S, Stiegler AL, Yi JS, Enyenihi L, et al
    SHP2 genetic variants in NSML-associated RASopathies disrupt the PZR-IRX transcription factor signaling axis.
    Proc Natl Acad Sci U S A. 2025;122:e2503631122.
    PubMed     Abstract available
    
    
    August 2025
35. KHAN F, Liu Y, Whitfield D, Pang L, et al
    Macrophage TBK1 signaling drives the development and outgrowth of breast cancer brain metastasis.
    Proc Natl Acad Sci U S A. 2025;122:e2420793122.
    PubMed     Abstract available
    
    
    
36. KARNER ER, Wang M, Goel HL, Mercurio AM, et al
    GATA3 promotes ferroptosis resistance by repressing integrin beta1 signaling.
    Proc Natl Acad Sci U S A. 2025;122:e2427304122.
    PubMed     Abstract available
    
    
    
37. PADRAO N, Gregoricchio S, Eickhoff N, Dong J, et al
    TRIM24 as a therapeutic target in endocrine treatment-resistant breast cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2507571122.
    PubMed     Abstract available
    
    
    
38. VUILLE JA, Tanriover C, Antmen E, Micalizzi DS, et al
    The E3 ligase HECTD4 regulates COX-2-dependent tumor progression and metastasis.
    Proc Natl Acad Sci U S A. 2025;122:e2425621122.
    PubMed     Abstract available
    
    
    July 2025
39. BOYER JA, Rosen EY, Sharma M, Dorso MA, et al
    eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2424286122.
    PubMed     Abstract available
    
    
    
40. HORWITZ E, Dubash TD, Szabolcs A, Wittner BS, et al
    CDKN1B (p27/kip1) enhances drug-tolerant persister CTCs by restricting polyploidy following mitotic inhibitors.
    Proc Natl Acad Sci U S A. 2025;122:e2507203122.
    PubMed     Abstract available
    
    
    
41. SUN R, Jiang P, Wang Z, Yan B, et al
    DNA2 protein destruction dictates DNA hyperexcision, cGAS-STING activation, and innate immune response in CDK12-deregulated cancers.
    Proc Natl Acad Sci U S A. 2025;122:e2413732122.
    PubMed     Abstract available
    
    
    
42. BARNET MB, Jackson KJL, Masle-Farquhar E, Russell A, et al
    Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy.
    Proc Natl Acad Sci U S A. 2025;122:e2314258122.
    PubMed     Abstract available
    
    
    
43. ZOU Y, Wang Z, Jiang Q, Kong X, et al
    UFMylation: A supervisor of the HIF1alpha pathway and a potential therapeutic target for anti-PD-1 combination therapy in hypoxic tumors.
    Proc Natl Acad Sci U S A. 2025;122:e2500562122.
    PubMed     Abstract available
    
    
    
44. SURYAWANSHI RK, Patil CD, Borase H, Shukla D, et al
    Akt isoform specificity drives intrinsic immune regulation during HSV-1 infection.
    Proc Natl Acad Sci U S A. 2025;122:e2504962122.
    PubMed     Abstract available
    
    
    
45. GUO J, Li K, Ming Y, Pan Y, et al
    A circular RNA overcomes acquired resistance to BET inhibitors by antagonizing IGF2BP2-mediated c-MYC translation in TNBC.
    Proc Natl Acad Sci U S A. 2025;122:e2504320122.
    PubMed     Abstract available
    
    
    
46. LIM J, Jung HD, Park SY, Jeon M, et al
    Genome-scale knockout simulation and clustering analysis of drug-resistant breast cancer cells reveal drug sensitization targets.
    Proc Natl Acad Sci U S A. 2025;122:e2425384122.
    PubMed     Abstract available
    
    
    June 2025
47. ZENG W, Guo H, Liu Q, Wong WH, et al
    Improving polygenic prediction from whole-genome sequencing data by leveraging predicted epigenomic features.
    Proc Natl Acad Sci U S A. 2025;122:e2419202122.
    PubMed     Abstract available
    
    
    
48. OZAKI MK, Zhang Y, Bartlett AQ, de Wilde E, et al
    Reproductive state controls transcription in the murine liver, with implications for breast cancer liver metastasis.
    Proc Natl Acad Sci U S A. 2025;122:e2420174122.
    PubMed     Abstract available
    
    
    
49. CROWTHER AJ, Kashem SW, Jewell ME, Le Chang H, et al
    Keratinocyte-TRPV1 sensory neuron interactions in a genetically controllable mouse model of chronic neuropathic itch.
    Proc Natl Acad Sci U S A. 2025;122:e2411724122.
    PubMed     Abstract available
    
    
    
50. DING Q, Liu J, Wang Y, Kim J, et al
    Dual-laser "808 and 1,064 nm" strategy that circumvents the Achilles' heel of photothermal therapy.
    Proc Natl Acad Sci U S A. 2025;122:e2503574122.
    PubMed     Abstract available
    
    
    
51. ZERILLO L, Zotti T, Tutela A, Madera JR, et al
    The CARD14sh-BCL10-MALT1 complex regulates MAVS-mediated antiviral response in keratinocytes.
    Proc Natl Acad Sci U S A. 2025;122:e2500711122.
    PubMed     Abstract available
    
    
    
52. SHARMA B, Aswin K, Jain T, Nasreen A, et al
    Mgat4b-mediated selective N-glycosylation regulates melanocyte development and melanoma progression.
    Proc Natl Acad Sci U S A. 2025;122:e2423831122.
    PubMed     Abstract available
    
    
    May 2025
53. FERRERO G, Cardamone MD, Luca F, Bourk E, et al
    Nonproteolytic ubiquitination regulates chromatin occupancy by the NCoR/SMRT/HDAC3 corepressor complex in MCF-7 breast cancer cells.
    Proc Natl Acad Sci U S A. 2025;122:e2502805122.
    PubMed     Abstract available
    
    
    April 2025
54. FOFFI E, Rugolo F, Ramamurthy N, Haight J, et al
    B cell-derived acetylcholine mitigates skin inflammation in mice through alpha9 nicotinic acetylcholine receptor-mediated signaling.
    Proc Natl Acad Sci U S A. 2025;122:e2501960122.
    PubMed     Abstract available
    
    
    
55. CHEN YF, Zhang QH, Zhang ZW, Zhou YJ, et al
    SNX10 deficiency impairs sensitivity to anti-HER2 antibody-drug conjugates via altering HER2 trafficking in HER2-positive breast cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2417586122.
    PubMed     Abstract available
    
    
    
56. ZHAO X, Zhao Y, Li Z, Liu H, et al
    Proximity-activated DNA scanning encoded sequencing for massive access to membrane proteins nanoscale organization.
    Proc Natl Acad Sci U S A. 2025;122:e2425000122.
    PubMed     Abstract available
    
    
    March 2025
57. NAZERAI L, Tsiavou C, Vardouli L, Schmiegelow K, et al
    Thiopurine therapy enhances immune checkpoint inhibitor efficacy in low-mutational burden melanoma: A promising anticancer approach.
    Proc Natl Acad Sci U S A. 2025;122:e2423246122.
    PubMed     Abstract available
    
    
    
58. STAROSTECKA M, Jeong H, Hasenfeld P, Benito-Garagorri E, et al
    Structural variant and nucleosome occupancy dynamics postchemotherapy in a HER2+ breast cancer organoid model.
    Proc Natl Acad Sci U S A. 2025;122:e2415475122.
    PubMed     Abstract available
    
    
    February 2025
59. YI J, Du J, Chen X, Nie RC, et al
    A circRNA-mRNA pairing mechanism regulates tumor growth and endocrine therapy resistance in ER-positive breast cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2420383122.
    PubMed     Abstract available
    
    
    
60. LEI L, Song Y, Yang L, Wang Y, et al
    Triethylamine-mediated protonation-deprotonation unlocks dual-drug self assembly to suppress breast cancer progression and metastasis.
    Proc Natl Acad Sci U S A. 2025;122:e2416796122.
    PubMed     Abstract available
    
    
    January 2025
61. KRAKOWIAK PA, Flores ME, Cuddy SR, Whitford AL, et al
    Co-option of mitochondrial nucleic acid-sensing pathways by HSV-1 UL12.5 for reactivation from latent infection.
    Proc Natl Acad Sci U S A. 2025;122:e2413965122.
    PubMed     Abstract available
    
    
    
62. CORRALES RM, Vincent J, Crobu L, Neish R, et al
    Tubulin detyrosination shapes Leishmania cytoskeletal architecture and virulence.
    Proc Natl Acad Sci U S A. 2025;122:e2415296122.
    PubMed     Abstract available
    
    
    
63. QIN G, Shao X, Liu X, Xu J, et al
    A signaling molecule from intratumor bacteria promotes trastuzumab resistance in breast cancer cells.
    Proc Natl Acad Sci U S A. 2025;122:e2421710122.
    PubMed     Abstract available
    
    
    
64. ZHENG M, Wang S, Tang K, Kong R, et al
    The CYLD-PARP1 feedback loop regulates DNA damage repair and chemosensitivity in breast cancer cells.
    Proc Natl Acad Sci U S A. 2025;122:e2413890121.
    PubMed     Abstract available
    
    
    December 2024
65. GONZALEZ-FERNANDEZ M, Perry C, Gerhards NM, Francica P, et al
    Docetaxel response in BRCA1,p53-deficient mammary tumor cells is affected by Huntingtin and BAP1.
    Proc Natl Acad Sci U S A. 2024;121:e2402849121.
    PubMed     Abstract available
    
    
    
66. CATTA-PRETA CMC, Ghosh K, Sacks DL, Ferreira TR, et al
    Single-cell atlas of Leishmania development in sandflies reveals the heterogeneity of transmitted parasites and their role in infection.
    Proc Natl Acad Sci U S A. 2024;121:e2406776121.
    PubMed     Abstract available
    
    
    
67. SINHA A, Saini KK, Chandramouli A, Tripathi K, et al
    ACSL4-mediated H3K9 and H3K27 hyperacetylation upregulates SNAIL to drive TNBC metastasis.
    Proc Natl Acad Sci U S A. 2024;121:e2408049121.
    PubMed     Abstract available
    
    
    
68. MATSUZAKI T, Fujii M, Noro H, Togo S, et al
    Simultaneous visualization of membrane fluidity and morphology defines adhesion signatures of cancer cells.
    Proc Natl Acad Sci U S A. 2024;121:e2412914121.
    PubMed     Abstract available
    
    
    
69. ROUBILLE S, Escure T, Juillard F, Corpet A, et al
    The HUSH epigenetic repressor complex silences PML nuclear body-associated HSV-1 quiescent genomes.
    Proc Natl Acad Sci U S A. 2024;121:e2412258121.
    PubMed     Abstract available
    
    
    November 2024
70. KASHYAP MP, Mishra B, Sinha R, Jin L, et al
    CD2 expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in hidradenitis suppurativa.
    Proc Natl Acad Sci U S A. 2024;121:e2409274121.
    PubMed     Abstract available
    
    
    
71. LADAK RJ, Choi JH, Luo J, Chen OJ, et al
    The 4EHP-mediated translational repression of cGAS impedes the host immune response against DNA viruses.
    Proc Natl Acad Sci U S A. 2024;121:e2413018121.
    PubMed     Abstract available
    
    
    
72. DING X, Liang J, Sharko AC, Hilimire TA, et al
    Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitors.
    Proc Natl Acad Sci U S A. 2024;121:e2414501121.
    PubMed     Abstract available
    
    
    
73. ARULRAJ T, Wang H, Deshpande A, Varadhan R, et al
    Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockade.
    Proc Natl Acad Sci U S A. 2024;121:e2410911121.
    PubMed     Abstract available
    
    
    October 2024
74. VALCIKOVA B, Vadovicova N, Smolkova K, Zacpalova M, et al
    eIF4F controls ERK MAPK signaling in melanomas with BRAF and NRAS mutations.
    Proc Natl Acad Sci U S A. 2024;121:e2321305121.
    PubMed     Abstract available
    
    
    
75. LI C, Kaur A, Pavlidaki A, Spenle C, et al
    Targeting the MAtrix REgulating MOtif abolishes several hallmarks of cancer, triggering antitumor immunity.
    Proc Natl Acad Sci U S A. 2024;121:e2404485121.
    PubMed     Abstract available
    
    
    
76. BALDASSARRI I, Tavakol DN, Graney PL, Chramiec AG, et al
    An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche.
    Proc Natl Acad Sci U S A. 2024;121:e2405257121.
    PubMed     Abstract available
    
    
    
77. ASEMOTA S, Effah W, Holt J, Johnson D, et al
    A molecular switch from tumor suppressor to oncogene in ER+ve breast cancer: Role of androgen receptor, JAK-STAT, and lineage plasticity.
    Proc Natl Acad Sci U S A. 2024;121:e2406837121.
    PubMed     Abstract available
    
    
    September 2024
78. FENG X, Yang C, Huang Y, Su D, et al
    In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2024;121:e2406325121.
    PubMed     Abstract available
    
    
    
79. LOY CJ, Servellita V, Sotomayor-Gonzalez A, Bliss A, et al
    Plasma cell-free RNA signatures of inflammatory syndromes in children.
    Proc Natl Acad Sci U S A. 2024;121:e2403897121.
    PubMed     Abstract available
    
    
    August 2024
80. MUKOHARA F, Iwata K, Ishino T, Inozume T, et al
    Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunity.
    Proc Natl Acad Sci U S A. 2024;121:e2320189121.
    PubMed     Abstract available
    
    
    
81. PIRONON N, Bourrat E, Prost C, Chen M, et al
    Splice modulation strategy applied to deep intronic variants in COL7A1 causing recessive dystrophic epidermolysis bullosa.
    Proc Natl Acad Sci U S A. 2024;121:e2401781121.
    PubMed     Abstract available
    
    
    
82. CHIANG HC, Qi L, Mitra P, Huang Y, et al
    R-loop functions in Brca1-associated mammary tumorigenesis.
    Proc Natl Acad Sci U S A. 2024;121:e2403600121.
    PubMed     Abstract available
    
    
    July 2024
83. SHAH OS, Nasrazadani A, Foldi J, Atkinson JM, et al
    Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations.
    Proc Natl Acad Sci U S A. 2024;121:e2322068121.
    PubMed     Abstract available
    
    
    
84. ZIN I, China A, Khan K, Nag JK, et al
    AKT-dependent nuclear localization of EPRS1 activates PARP1 in breast cancer cells.
    Proc Natl Acad Sci U S A. 2024;121:e2303642121.
    PubMed     Abstract available
    
    
    
85. ZHOU Q, Yu H, Chen Y, Ren J, et al
    The CRL3(KCTD10) ubiquitin ligase-USP18 axis coordinately regulates cystine uptake and ferroptosis by modulating SLC7A11.
    Proc Natl Acad Sci U S A. 2024;121:e2320655121.
    PubMed     Abstract available
    
    
    June 2024
86. DI LEO L, Pagliuca C, Kishk A, Rizza S, et al
    AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.
    Proc Natl Acad Sci U S A. 2024;121:e2400566121.
    PubMed     Abstract available
    
    
    
87. RUAN ML, Ni WX, Chu JCH, Lam TL, et al
    Iridium(III) carbene complexes as potent girdin inhibitors against metastatic cancers.
    Proc Natl Acad Sci U S A. 2024;121:e2316615121.
    PubMed     Abstract available
    
    
    
88. NEBO ID, Frew JW, Gudjonsson JE, Petukhova L, et al
    Tissue comparability and bias in hidradenitis suppurativa transcriptomic studies.
    Proc Natl Acad Sci U S A. 2024;121:e2404503121.
    PubMed    
    
    
    
89. JIN L, Kashyap MP, Haque ST, Li C, et al
    Reply to Nebo et al.: Pathogenesis of advanced hidradenitis suppurativa: Are there differences based on anatomical location, gender, and race?
    Proc Natl Acad Sci U S A. 2024;121:e2405298121.
    PubMed    
    
    
    May 2024
90. 
    Correction for Ichimura et al., Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice.
    Proc Natl Acad Sci U S A. 2024;121:e2408646121.
    PubMed    
    
    
    
91. CHEN J, Liu X, Zou Y, Gong J, et al
    A high-fat diet promotes cancer progression by inducing gut microbiota-mediated leucine production and PMN-MDSC differentiation.
    Proc Natl Acad Sci U S A. 2024;121:e2306776121.
    PubMed     Abstract available
    
    
    
92. ASHOKAN A, Sarkar S, Kamran MZ, Surnar B, et al
    Simultaneous targeting of peripheral and brain tumors with a therapeutic nanoparticle to disrupt metabolic adaptability at both sites.
    Proc Natl Acad Sci U S A. 2024;121:e2318119121.
    PubMed     Abstract available
    
    
    
93. GOYETTE MA, Stevens LE, DePinho CR, Seehawer M, et al
    Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies.
    Proc Natl Acad Sci U S A. 2024;121:e2322688121.
    PubMed     Abstract available
    
    
    April 2024
94. MONDAL DK, Xie C, Pascal GJ, Buraschi S, et al
    Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression.
    Proc Natl Acad Sci U S A. 2024;121:e2317760121.
    PubMed     Abstract available
    
    
    
95. ICHIMURA Y, Konishi R, Shobo M, Tanaka R, et al
    Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice.
    Proc Natl Acad Sci U S A. 2024;121:e2313070121.
    PubMed     Abstract available
    
    
    
96. PIRES L, Khattak S, Pratavieira S, Calcada C, et al
    Femtosecond pulsed laser photodynamic therapy activates melanin and eradicates malignant melanoma.
    Proc Natl Acad Sci U S A. 2024;121:e2316303121.
    PubMed     Abstract available
    
    
    March 2024
97. WANG D, Tang M, Zhang P, Yang K, et al
    Activation of ERbeta hijacks the splicing machinery to trigger R-loop formation in triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2024;121:e2306814121.
    PubMed     Abstract available
    
    
    
98. GOUPIL E, Lacroix L, Briere J, Guga S, et al
    OSGN-1 is a conserved flavin-containing monooxygenase required to stabilize the intercellular bridge in late cytokinesis.
    Proc Natl Acad Sci U S A. 2024;121:e2308570121.
    PubMed     Abstract available
    
    
    
99. TAYLOR-PHILLIPS S, Jenkinson D, Stinton C, Kunar MA, et al
    Fatigue and vigilance in medical experts detecting breast cancer.
    Proc Natl Acad Sci U S A. 2024;121:e2309576121.
    PubMed     Abstract available
    
    
    
100. LAMIA KA
     Telling time in tumor samples reveals diversity of clock disruption.
     Proc Natl Acad Sci U S A. 2024;121:e2401496121.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum